Director received an award of 591 CVS shares | OQRO Insider tradesWhy it stands out
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Nov 20, 2025
- Reporting period
- Not applicable
- Filed with the SEC
- Nov 21, 2025
DirectorGrant / award
Context
- Classification
grant award
Code A — grant or award
- Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0000064803-25-000061
- Filed / recorded
Added to OQROOct 2, 2026, 3:52 AM UTC Data qualityVerified: identifiers matched exactly Reporting personAnne A. Finucane TableNon-derivative (Table I) Transaction dateNov 20, 2025 Acquired / disposedAcquired (A) Footnotes from the filing
- Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan.
Around the same time
Congress tradeSits on House Ways and Means, Health4 different filers disclosed CVS within 90 days. Disclosed 28 days after the transaction; reported as an official range, not an exact amount.
Routine share withholding; mechanical by default.
Routine share withholding; mechanical by default.
